PrP mRNA and protein expression in brain and PrP^c in CSF in Creutzfeldt-Jakob disease MM1 and VV2

References

• Aguzzi A, Sigurdson C, Heikenwaelder M. Molecular mechanisms of prion pathogenesis. Annu Rev Pathol 2008; 3:11 - 40; http://dx.doi.org/10.1146/annurev.pathmechdis.3.121806.154326; PMID: 18233951
   PubMed Web of Science ®Google Scholar
• Colby DW, Prusiner SB. Prions. Cold Spring Harb Perspect Biol 2011; 3:a006833; http://dx.doi.org/10.1101/cshperspect.a006833; PMID: 21421910
   PubMed Web of Science ®Google Scholar
• Aguzzi A, Heikenwalder M, Polymenidou M. Insights into prion strains and neurotoxicity. Nat Rev Mol Cell Biol 2007; 8:552 - 61; http://dx.doi.org/10.1038/nrm2204; PMID: 17585315
   PubMed Web of Science ®Google Scholar
• Parchi P, Castellani R, Capellari S, Ghetti B, Young K, Chen SG, Farlow M, Dickson DW, Sima AA, Trojanowski JQ, et al. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol 1996; 39:767 - 78; http://dx.doi.org/10.1002/ana.410390613; PMID: 8651649
   PubMed Web of Science ®Google Scholar
• Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O, Zerr I, Budka H, Kopp N, Piccardo P, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999; 46:224 - 33; http://dx.doi.org/10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; PMID: 10443888
   PubMed Web of Science ®Google Scholar
• Head MW, Ironside JW. Review: Creutzfeldt-Jakob disease: prion protein type, disease phenotype and agent strain. Neuropathol Appl Neurobiol 2012; 38:296 - 310; http://dx.doi.org/10.1111/j.1365-2990.2012.01265.x; PMID: 22394291
   PubMed Web of Science ®Google Scholar
• Parchi P, Saverioni D. Molecular pathology, classification, and diagnosis of sporadic human prion disease variants. Folia Neuropathol 2012; 50:20 - 45; PMID: 22505361
   PubMed Web of Science ®Google Scholar
• Puoti G, Bizzi A, Forloni G, Safar JG, Tagliavini F, Gambetti P. Sporadic human prion diseases: molecular insights and diagnosis. Lancet Neurol 2012; 11:618 - 28; http://dx.doi.org/10.1016/S1474-4422(12)70063-7; PMID: 22710755
   PubMed Web of Science ®Google Scholar
• Herms J, Tings T, Gall S, Madlung A, Giese A, Siebert H, Schürmann P, Windl O, Brose N, Kretzschmar H. Evidence of presynaptic location and function of the prion protein. J Neurosci 1999; 19:8866 - 75; PMID: 10516306
   PubMed Web of Science ®Google Scholar
• Büeler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M, Weissmann C. Mice devoid of PrP are resistant to scrapie. Cell 1993; 73:1339 - 47; http://dx.doi.org/10.1016/0092-8674(93)90360-3; PMID: 8100741
   PubMed Web of Science ®Google Scholar
• Riemenschneider M, Wagenpfeil S, Vanderstichele H, Otto M, Wiltfang J, Kretzschmar H, Vanmechelen E, Förstl H, Kurz A. Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias. Mol Psychiatry 2003; 8:343 - 7; http://dx.doi.org/10.1038/sj.mp.4001220; PMID: 12660807
   PubMed Web of Science ®Google Scholar
• Sanchez-Juan P, Green A, Ladogana A, Cuadrado-Corrales N, Sáanchez-Valle R, Mitrováa E, Stoeck K, Sklaviadis T, Kulczycki J, Hess K, et al. CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 2006; 67:637 - 43; http://dx.doi.org/10.1212/01.wnl.0000230159.67128.00; PMID: 16924018
   PubMed Web of Science ®Google Scholar
• Weber T, Otto M, Bodemer M, Zerr I. Diagnosis of Creutzfeldt-Jakob disease and related human spongiform encephalopathies. Biomed Pharmacother 1997; 51:381 - 7; http://dx.doi.org/10.1016/S0753-3322(97)89430-9; PMID: 9452787
   PubMed Web of Science ®Google Scholar
• Zerr I, Bodemer M, Gefeller O, Otto M, Poser S, Wiltfang J, Windl O, Kretzschmar HA, Weber T. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol 1998; 43:32 - 40; http://dx.doi.org/10.1002/ana.410430109; PMID: 9450766
   PubMed Web of Science ®Google Scholar
• Wong BS, Green AJ, Li R, Xie Z, Pan T, Liu T, Chen SG, Gambetti P, Sy MS. Absence of protease-resistant prion protein in the cerebrospinal fluid of Creutzfeldt-Jakob disease. J Pathol 2001; 194:9 - 14; http://dx.doi.org/10.1002/path.872; PMID: 11329135
   PubMed Web of Science ®Google Scholar
• Meyne F, Gloeckner SF, Ciesielczyk B, Heinemann U, Krasnianski A, Meissner B, Zerr I. Total prion protein levels in the cerebrospinal fluid are reduced in patients with various neurological disorders. J Alzheimers Dis 2009; 17:863 - 73; PMID: 19542614
   PubMed Web of Science ®Google Scholar
• Torres M, Cartier L, Matamala JM, Hernández N, Woehlbier U, Hetz C. Altered Prion protein expression pattern in CSF as a biomarker for Creutzfeldt-Jakob disease. PLoS One 2012; 7:e36159; http://dx.doi.org/10.1371/journal.pone.0036159; PMID: 22558368
   PubMed Web of Science ®Google Scholar
• Esiri MM, Carter J, Ironside JW. Prion protein immunoreactivity in brain samples from an unselected autopsy population: findings in 200 consecutive cases. Neuropathol Appl Neurobiol 2000; 26:273 - 84; http://dx.doi.org/10.1046/j.1365-2990.2000.00239.x; PMID: 10886685
   PubMed Web of Science ®Google Scholar
• Sørby R, Austbø L, Press CM, Skretting G, Landsverk T, Espenes A. PrP expression, PrPSc accumulation and innervation of splenic compartments in sheep experimentally infected with scrapie. PLoS One 2009; 4:e6885; http://dx.doi.org/10.1371/journal.pone.0006885; PMID: 19727393
   PubMedGoogle Scholar
• Rudd PM, Endo T, Colominas C, Groth D, Wheeler SF, Harvey DJ, Wormald MR, Serban H, Prusiner SB, Kobata A, et al. Glycosylation differences between the normal and pathogenic prion protein isoforms. Proc Natl Acad Sci U S A 1999; 96:13044 - 9; http://dx.doi.org/10.1073/pnas.96.23.13044; PMID: 10557270
   PubMed Web of Science ®Google Scholar
• Winklhofer KF, Heller U, Reintjes A, Tatzelt J. Inhibition of complex glycosylation increases the formation of PrPsc. Traffic 2003; 4:313 - 22; http://dx.doi.org/10.1034/j.1600-0854.2003.00088.x; PMID: 12713659
   PubMed Web of Science ®Google Scholar
• Cancellotti E, Bradford BM, Tuzi NL, Hickey RD, Brown D, Brown KL, Barron RM, Kisielewski D, Piccardo P, Manson JC. Glycosylation of PrPC determines timing of neuroinvasion and targeting in the brain following transmissible spongiform encephalopathy infection by a peripheral route. J Virol 2010; 84:3464 - 75; http://dx.doi.org/10.1128/JVI.02374-09; PMID: 20106922
   PubMed Web of Science ®Google Scholar
• Cancellotti E, Mahal SP, Somerville R, Diack A, Brown D, Piccardo P, Weissmann C, Manson JC. Post-translational changes to PrP alter transmissible spongiform encephalopathy strain properties. EMBO J 2013; 32:756 - 69; http://dx.doi.org/10.1038/emboj.2013.6; PMID: 23395905
   PubMed Web of Science ®Google Scholar
• Ferrer I, Puig B, Blanco R, Martí E. Prion protein deposition and abnormal synaptic protein expression in the cerebellum in Creutzfeldt-Jakob disease. Neuroscience 2000; 97:715 - 26; http://dx.doi.org/10.1016/S0306-4522(00)00045-2; PMID: 10842016
   PubMed Web of Science ®Google Scholar
• Ferrer I, Rivera R, Blanco R, Martí E. Expression of proteins linked to exocytosis and neurotransmission in patients with Creutzfeldt-Jakob disease. Neurobiol Dis 1999; 6:92 - 100; http://dx.doi.org/10.1006/nbdi.1998.0226; PMID: 10343324
   PubMed Web of Science ®Google Scholar
• Jeffrey M, McGovern G, Sisó S, González L. Cellular and sub-cellular pathology of animal prion diseases: relationship between morphological changes, accumulation of abnormal prion protein and clinical disease. Acta Neuropathol 2011; 121:113 - 34; http://dx.doi.org/10.1007/s00401-010-0700-3; PMID: 20532540
   PubMed Web of Science ®Google Scholar
• Corsaro A, Thellung S, Villa V, Nizzari M, Florio T. Role of prion protein aggregation in neurotoxicity. Int J Mol Sci 2012; 13:8648 - 69; http://dx.doi.org/10.3390/ijms13078648; PMID: 22942726
   PubMed Web of Science ®Google Scholar
• Simoneau S, Rezaei H, Salès N, Kaiser-Schulz G, Lefebvre-Roque M, Vidal C, Fournier JG, Comte J, Wopfner F, Grosclaude J, et al. In vitro and in vivo neurotoxicity of prion protein oligomers. PLoS Pathog 2007; 3:e125; http://dx.doi.org/10.1371/journal.ppat.0030125; PMID: 17784787
   PubMed Web of Science ®Google Scholar
• Laurén J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 2009; 457:1128 - 32; http://dx.doi.org/10.1038/nature07761; PMID: 19242475
   PubMed Web of Science ®Google Scholar
• Um JW, Nygaard HB, Heiss JK, Kostylev MA, Stagi M, Vortmeyer A, Wisniewski T, Gunther EC, Strittmatter SM. Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons. Nat Neurosci 2012; 15:1227 - 35; http://dx.doi.org/10.1038/nn.3178; PMID: 22820466
   PubMed Web of Science ®Google Scholar
• Kudo W, Lee HP, Zou WQ, Wang X, Perry G, Zhu X, Smith MA, Petersen RB, Lee HG. Cellular prion protein is essential for oligomeric amyloid-β-induced neuronal cell death. Hum Mol Genet 2012; 21:1138 - 44; http://dx.doi.org/10.1093/hmg/ddr542; PMID: 22100763
   PubMed Web of Science ®Google Scholar
• Larson M, Sherman MA, Amar F, Nuvolone M, Schneider JA, Bennett DA, Aguzzi A, Lesné SE. The complex PrP(c)-Fyn couples human oligomeric Aβ with pathological tau changes in Alzheimer’s disease. J Neurosci 2012; 32:16857 - 71a; http://dx.doi.org/10.1523/JNEUROSCI.1858-12.2012; PMID: 23175838
   PubMed Web of Science ®Google Scholar
• Windl O, Giese A, Schulz-Schaeffer W, Zerr I, Skworc K, Arendt S, Oberdieck C, Bodemer M, Poser S, Kretzschmar HA. Molecular genetics of human prion diseases in Germany. Hum Genet 1999; 105:244 - 52; http://dx.doi.org/10.1007/s004390051096; PMID: 10987652
   PubMed Web of Science ®Google Scholar